Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Long-Term Deferred Tax (2016 - 2019)

Historic Long-Term Deferred Tax for Sanara MedTech (SMTI) over the last 6 years, with Q4 2019 value amounting to $1.9 million.

  • Sanara MedTech's Long-Term Deferred Tax changed N/A to $1.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $1.9 million for FY2019, which is N/A changed from last year.
  • According to the latest figures from Q4 2019, Sanara MedTech's Long-Term Deferred Tax is $1.9 million.
  • In the past 5 years, Sanara MedTech's Long-Term Deferred Tax ranged from a high of $11.8 million in Q4 2016 and a low of $1.9 million during Q4 2019
  • In the last 4 years, Sanara MedTech's Long-Term Deferred Tax had a median value of $9.5 million in 2015 and averaged $8.2 million.
  • Per our database at Business Quant, Sanara MedTech's Long-Term Deferred Tax increased by 4.56% in 2016 and then plummeted by 3807.92% in 2017.
  • Quarter analysis of 4 years shows Sanara MedTech's Long-Term Deferred Tax stood at $11.8 million in 2015, then rose by 0.05% to $11.8 million in 2016, then plummeted by 38.08% to $7.3 million in 2017, then tumbled by 74.28% to $1.9 million in 2019.
  • Its Long-Term Deferred Tax stands at $1.9 million for Q4 2019, versus $7.3 million for Q4 2017 and $11.8 million for Q4 2016.